NCT06406712 Retroclavicular Block in Vascular Surgey
| NCT ID | NCT06406712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | New Valley University |
| Condition | Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-06-01 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The retroclavicular (coracoid) approach for brachial plexus anesthesia is recognized for its facility and simplicity to perform . The block has been well described in the anesthesia community since it was first introduced by Hebbard and Royse in 2007 . In 2017, Luftig . first described the block's use in the ED setting for a variety of indications . Because of its different needle entry point, the retro clavicular (RCB) approach offers an almost perpendicular needle-ultrasound (US) beam angle.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing upper limb vascular surgey . Exclusion Criteria: * \- Contraindications to regional block (coagulopathy, infection at the needle insertion site, or diaphragmatic paralysis). * Altered conscious level. * Pregnancy. * Body mass index (BMI \> 35). * Patients who have difficulty understanding the study protocol. * Patients who have any known contraindication to study medications. * Patient refusal.
Contact & Investigator
ahmed ismail, lecture
PRINCIPAL INVESTIGATOR
faculty of medicine , new valley university
Frequently Asked Questions
Who can join the NCT06406712 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 65 Years, studying Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06406712 currently recruiting?
Yes, NCT06406712 is actively recruiting participants. Contact the research team at ahmed_ismail87@med.nvu.edu.eg for enrollment information.
Where is the NCT06406712 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT06406712 clinical trial?
NCT06406712 is sponsored by New Valley University. The principal investigator is ahmed ismail, lecture at faculty of medicine , new valley university. The trial plans to enroll 80 participants.